Hydrocodone Extended-Release Tablets and Paraplatin NovaPlus
Determining the interaction of Hydrocodone Extended-Release Tablets and Paraplatin NovaPlus and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: carboplatin
Brand name: Paraplatin, CARBOplatin Novaplus
Synonyms: Paraplatin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Tablets-Parathyroid hormone
- Hydrocodone Extended-Release Tablets-Parathyroid hormone Subcutaneous
- Hydrocodone Extended-Release Tablets-Parcopa
- Hydrocodone Extended-Release Tablets-Paregoric
- Hydrocodone Extended-Release Tablets-Paremyd
- Hydrocodone Extended-Release Tablets-Paremyd Ophthalmic
- Paraplatin NovaPlus-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Paraplatin NovaPlus-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Paraplatin NovaPlus-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Paraplatin NovaPlus-Hydrocortisone
- Paraplatin NovaPlus-Hydrocortisone (Systemic)
- Paraplatin NovaPlus-Hydrocortisone 2.5%